MADISON HEIGHTS, Mich.,
April 30 /PRNewswire/ -- The
Editorial Advisory and Securities Review Committee of
BetterInvesting Magazine today announced Teva Pharmaceutical
Industries Limited (Nasdaq: TEVA) as its July 2010 "Stock to Study" and Gilead Sciences,
Inc. (Nasdaq: GILD) as its July "Undervalued Stock" for investors'
informational and educational use.
"The committee chose Teva Pharmaceutical Industries because of
the tremendous growth opportunities for generic drugs and the
company's expertise and leadership in this industry," said
Adam Ritt, editor of BetterInvesting
Magazine. "For the Undervalued selection, the valuation of Gilead
Sciences' stock was viewed as quite attractive in light of its
growth." Check the BetterInvesting website in June for more details
about these selections.
Committee members are Robert M. Bilkie,
Jr., CFA; Daniel J. Boyle,
CFA; Philip S. Dano, CFA;
Donald E. Danko, CFA; Maury Elvekrog, CFA; Walter J. Kirchberger, CFA; and Marisa Lenhard, CFA.
As stated, the BetterInvesting committee's Stock to Study and
Undervalued Stock choices are for the informational and educational
uses of investors and are not intended as investment
recommendations. BetterInvesting urges investors to educate
themselves about the stock market so they can make informed
decisions about stock purchases. For more information about
investment education tools available to individual investors and
investment clubs visit www.betterinvesting.org.
Follow us on Twitter and Facebook.
BetterInvesting Magazine is published monthly by
BetterInvesting.
BetterInvesting is the brand identity of the National Association
of Investors Corporation, a national, nonprofit association with
members consisting of individual investors and investment clubs.
Founded in 1951 and with headquarters in Madison Heights, Mich., BetterInvesting is
considered the voice of the individual investor, as well as the
pioneer of the modern investment club movement. BetterInvesting is
dedicated to providing a sound program of investment education and
information to help its members become successful long-term,
lifetime investors. For more information about BetterInvesting,
visit its website at www.betterinvesting.org or call toll free
(877) 275-6242. For additional BetterInvesting data and news
releases, visit the Media Center at
www.betterinvesting.org/mediacenter.
SOURCE BetterInvesting